<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02730663</url>
  </required_header>
  <id_info>
    <org_study_id>SPAXUS-001</org_study_id>
    <nct_id>NCT02730663</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Effectiveness and Safety of EUS-guided Transluminal Drainage With 'Niti-S SPAXUS Stent'</brief_title>
  <official_title>A Prospective, Multi-center, Single Arm, Non-inferiority, Open-label, Pivotal Study to Evaluate the Effectiveness and Safety of EUS -Guided Transluminal Drainage With 'Niti-S SPAXUS Stent' for the Treatment of Pancreatic Pseudocyst</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taewoong Medical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taewoong Medical Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of endoscopic
      ultrasound (EUS)-guided transluminal drainage with 'Niti-S SPAXUS Stent' for the treatment of
      pancreatic pseudocyst.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      'Niti-S SPAXUS Stent' is a newly designed lumen-apposing fully covered self-expandable metal
      stent. It is indicated for use in patients with pancreatic pseudocyst. Consecutive subject
      data should be collected at discharge, stent removal (day 30 or 60), and day 20 post Niti-S
      SPAXUS stent removal.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 21, 2016</start_date>
  <completion_date type="Actual">June 14, 2017</completion_date>
  <primary_completion_date type="Actual">June 14, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical success</measure>
    <time_frame>at stent removal (Day 30 or 60)</time_frame>
    <description>Clinical success is defined as ≥50% decrease in pancreatic pseudocyst size measured on Computed Tomography (CT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>1day</time_frame>
    <description>Technical success is defined as successful placement of the Niti-S SPAXUS stent across the gastric(or duodenal) wall to the pseudocyst with visualization of the pseudocyst fluid drainage through the stent by endoscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent lumen patency</measure>
    <time_frame>up to 60 days (at stent removal, Day 30 or 60)</time_frame>
    <description>Stent lumen patency will be evaluated by endoscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent removal success</measure>
    <time_frame>up to 60 days (at stent removal, Day 30 or 60)</time_frame>
    <description>Stent removal success is defined as successful removal of the Niti-S SPAXUS stent using a standard endoscopic forceps or snare.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure time</measure>
    <time_frame>1 day</time_frame>
    <description>Procedure time is measured as time from insertion until removal of endoscope.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural / Device related serious adverse events</measure>
    <time_frame>up to 90 days (at Day 20 post stent removal)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other adverse events</measure>
    <time_frame>up to 90 days (at Day 20 post stent removal)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Pancreatic Pseudocyst</condition>
  <arm_group>
    <arm_group_label>Niti-S SPAXUS Stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Niti-S SPAXUS Stent (TaeWoong Medical Co., Ltd. Korea)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Niti-S SPAXUS Stent</intervention_name>
    <description>Endoscopic Ultrasound-Guided Transluminal drainage</description>
    <arm_group_label>Niti-S SPAXUS Stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pancreatic pseudocyst ≥6cm in size, with ≥70% fluid content that is eligible for
             transluminal drainage

          -  Patient willing to provide written informed consent and comply with follow-up
             requirements

        Exclusion Criteria:

          -  Ineligible for endoscopic intervention

          -  Pancreatic pseudocyst with severe internal septation

          -  Platelet count &lt; 60,000 cells/mm3 or INR &gt;1.5

          -  Hemodynamic instability (e.g. shock)

          -  Active infectious disease (e.g. endocarditis, meningitis)

          -  Participating in any other investigational drug or device clinical trial within past 3
             months

          -  Female of child-bearing potential who are unable to take adequate contraceptive
             precautions, are known to be pregnant, or are currently breastfeeding an infant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jong Ho Moon, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soon Chun Hyang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sang Soo Lee, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jong Kyun Lee, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seung-Ok Lee, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonbuk National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chang Min Cho, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungpook National University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Se Woo Park, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hallym University Dongtan Sacred Heart Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Soon Chun Hyang University Hospital Bucheon</name>
      <address>
        <city>Bucheon</city>
        <state>Gyeonggi-do</state>
        <zip>14584</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hallym University Dongtan Sacred Heart Hospital</name>
      <address>
        <city>Hwaseong-si</city>
        <state>Gyeonggi-do</state>
        <zip>18450</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyungpook National University Medical Center</name>
      <address>
        <city>Daegu</city>
        <zip>41404</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonbook National University Hospital</name>
      <address>
        <city>Jeonju</city>
        <zip>54907</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2016</study_first_submitted>
  <study_first_submitted_qc>March 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2016</study_first_posted>
  <last_update_submitted>October 11, 2017</last_update_submitted>
  <last_update_submitted_qc>October 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endoscopic ultrasound guided transluminal drainage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Pseudocyst</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Oct, 2016</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

